Revue des publications scientifiques de juin 2013

1.      VBM Reveals Brain Volume Differences between Parkinson’s Disease and Essential Tremor Patients.
Lin CH, Chen CM, Lu MK, Tsai CH, Chiou JC, Liao JR, Duann JR.
Front Hum Neurosci. 2013 Jun 14;7:247.
doi: 10.3389/fnhum.2013.00247.
2. Effects of low-frequency thalamic deep brain stimulation in essential tremor patients.
Pedrosa DJ, Auth M, Eggers C, Timmermann L.
Exp Neurol. 2013 Jun 15.
doi:pii: S0014-4886(13)00182-9. 10.1016/j.expneurol.2013.06.009.
3. Genetic Analysis of the Leucine-Rich Repeat and lg Domain Containing Nogo Receptor-Interacting Protein 1 Gene in Essential Tremor.
Liang H, Song Z, Deng X, Xu H, Zhu A, Zheng W, Zhao Y, Deng H.
J Mol Neurosci. 2013 Jun 12.
4. Effect of lead trajectory on the response of essential head tremor to deep brain stimulation.
Moscovich M, Morishita T, Foote KD, Favilla CG, Chen ZP, Okun MS.
Parkinsonism Relat Disord. 2013 Jun 3.
doi:pii: S1353-8020(13)00131-4. 10.1016/j.parkreldis.2013.03.015.
5. A normal inferior olive in essential tremor-peacemaker or pacemaker?
Saifee TA, Edwards MJ.
Mov Disord. 2013 Jun;28(6):694-6.
doi: 10.1002/mds.25485. Epub 2013 May 31.
6. Pathological tremor prediction using surface electromyogram and acceleration: potential use in ‘ON-OFF’ demand driven deep brain stimulator design.
Basu I, Graupe D, Tuninetti D, Shukla P, Slavin KV, Metman LV, Corcos DM.
J Neural Eng. 2013 Jun;10(3):036019.
doi: 10.1088/1741-2560/10/3/036019.
7. What is essential tremor?
Elble RJ.
Curr Neurol Neurosci Rep. 2013 Jun;13(6):353.
doi: 10.1007/s11910-013-0353-4.
8. Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau.
Kuo SH, Tang G, Louis ED, Ma K, Babji R, Balatbat M, Cortes E, Vonsattel JP, Yamamoto A, Sulzer D, Faust PL.
Acta Neuropathol. 2013 Jun;125(6):879-89.
doi: 10.1007/s00401-013-1108-7.
9. Essential tremor 10, 20, 30, 40: clinical snapshots of the disease by decade of duration.
Louis ED, Gerbin M, Galecki M.
Eur J Neurol. 2013 Jun;20(6):949-54.
doi: 10.1111/ene.12123.
10. The inferior olivary nucleus: A postmortem study of essential tremor cases versus controls.
Louis ED, Babij R, Cortés E, Vonsattel JP, Faust PL.
Mov Disord. 2013 Jun;28(6):779-86.
doi: 10.1002/mds.25400.
11. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J.
Toxicon. 2013 Jun 1;67:94-114.
doi: 10.1016/j.toxicon.2012.12.004.
12. Investigation of the prevalence of essential tremor in individuals aged 18-60 in Erzurum.
Ozel L, Demir R, Ozdemir G, Ozyıldırım E, Avşar U, Ulvi H, Aygül R.
Acta Neurol Belg. 2013 Jun;113(2):127-31.
doi: 10.1007/s13760-012-0147-5.
13. Clinical and cognitive profiles of patients with both Parkinson’s disease and essential tremor.
Ozen Barut B, Gunal DI, Turkmen C, Mollahasanoğlu A, Ankaralı H.
Acta Neurol Belg. 2013 Jun;113(2):117-25.
doi: 10.1007/s13760-012-0124-z.